Vanderbilt Scientists Make Headway in Drug Development to Cure Pulmonary Arterial Hypertension
September 14, 2023
September 14, 2023
NASHVILLE, Tennessee, Sept. 14 (TNSres) -- Vanderbilt University issued the following news:
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension--a type of high blood pressure that affects arteries in the lungs and in the heart--without serious neurological side effects.
Merryman conducted th . . .
Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension--a type of high blood pressure that affects arteries in the lungs and in the heart--without serious neurological side effects.
Merryman conducted th . . .